Commonwealth Equity Services’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-27,091
Closed -$4.8M 3048
2020
Q1
$4.8M Sell
27,091
-1,682
-6% -$317K 0.02% 569
2019
Q4
$5.5M Sell
28,773
-216
-0.7% -$39K 0.02% 595
2019
Q3
$4.88M Sell
28,989
-3,518
-11% -$573K 0.02% 601
2019
Q2
$5.44M Sell
32,507
-13,293
-29% -$1.84M 0.02% 540
2019
Q1
$6.71M Buy
45,800
+403
+0.9% +$58.4K 0.03% 475
2018
Q4
$6.07M Sell
45,397
-5,192
-10% -$851K 0.03% 450
2018
Q3
$9.64M Sell
50,589
-4,287
-8% -$788K 0.05% 358
2018
Q2
$9.15M Buy
54,876
+5,572
+11% +$895K 0.05% 338
2018
Q1
$8.3M Sell
49,304
-208
-0.4% -$34.9K 0.05% 342
2017
Q4
$8.1M Buy
49,512
+3,953
+9% +$709K 0.04% 341
2017
Q3
$9.34M Buy
45,559
+2,948
+7% +$686K 0.06% 289
2017
Q2
$10.4M Buy
42,611
+3,729
+10% +$876K 0.07% 261
2017
Q1
$9.29M Sell
38,882
-652
-2% -$152K 0.06% 275
2016
Q4
$8.3M Buy
39,534
+2,222
+6% +$460K 0.06% 282
2016
Q3
$8.59M Buy
37,312
+6,027
+19% +$1.47M 0.07% 257
2016
Q2
$7.23M Buy
31,285
+4,198
+15% +$968K 0.06% 280
2016
Q1
$7.26M Buy
27,087
+1,405
+5% +$402K 0.06% 274
2015
Q4
$8.03M Sell
25,682
-3,033
-11% -$903K 0.08% 241
2015
Q3
$7.8M Sell
28,715
-2,225
-7% -$683K 0.08% 225
2015
Q2
$9.39M Buy
30,940
+1,544
+5% +$461K 0.09% 213
2015
Q1
$8.75M Buy
29,396
+363
+1% +$103K 0.09% 214
2014
Q4
$7.47M Buy
29,033
+9,287
+47% +$2.32M 0.08% 226
2014
Q3
$4.76M Buy
19,746
+9,570
+94% +$2.14M 0.06% 291
2014
Q2
$2.27M Buy
10,176
+378
+4% +$78.3K 0.03% 514
2014
Q1
$2.02M Sell
9,798
-7,622
-44% -$1.51M 0.03% 517
2013
Q4
$2.93M Buy
17,420
+13,380
+331% +$2.09M 0.04% 359
2013
Q3
$582K Sell
4,040
-52
-1% -$6.93K 0.01% 1016
2013
Q2
$516K Buy
+4,092
New +$463K 0.01% 1008

Other funds holding AGN

Commonwealth Equity Services's AGN Position: Q2 2020 in Review

Commonwealth Equity Services sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 27,091 shares — an estimated $4.8M sold.

Commonwealth Equity Services first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $10.4M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Commonwealth Equity Services reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Commonwealth Equity Services sold 27,091 Allergan plc shares in Q2 2020, an estimated $4.8M.
  • Commonwealth Equity Services first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Commonwealth Equity Services's Allergan plc position peaked at $10.4M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Commonwealth Equity Services's 13F filing for Q2 2020, filed 12 Aug 2020.